An Open Label Phase I Study to Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies.
Phase of Trial: Phase I
Latest Information Update: 02 Jun 2009
At a glance
- Drugs Patupilone (Primary) ; Warfarin
- Indications Cancer
- Focus Pharmacokinetics
- Sponsors Novartis; Novartis Pharmaceuticals
- 02 Jun 2009 Actual number of patients (17) added as reported by ClinicalTrials.gov.
- 02 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 May 2007 New trial record.